Hein van den Bos helps Life Sciences companies with EU and Dutch regulatory matters. He assists pharmaceutical, biotech and medical devices companies on matters relating to the development, approval and marketing of their products. This includes assistance on life cycle management issues such as regulatory data exclusivity and orphan exclusivity, pharmacovigilance, clinical trials, distribution and advertising and promotion.
He also assists on a number of compliance matters, such as financial relations with healthcare professionals, anti-corruption and sunshine rules. Furthermore, Hein helps companies with pricing and reimbursement matters in the Netherlands as well as with Dutch government investigations and enforcement measures.